Monographie - Vinblastine sulfate

Cập nhật lần cuối :
08/05/2024

Vinblastine sulfate

Cấu trúc hóa học

Tên thương mại

Các tên thương mại được cung cấp và thành phần tá dược có thể khác nhau giữa các quốc gia và các hãng dược

Blestinib	Mexico
Cytoblastin	Ả Rập, Malaysia
Lemblastine	Chile, Colombia, Mexico
Oncoblastin	Colombia
Uniblastin	Peru
VBlastin	Ấn Độ
Velbe	Ả Rập Saudi, Anh, Áo, Chile, Hà Lan, Hy Lạp, Luxembourg, Morocco, Na Uy, Phần Lan, Pháp, Thụy Sỹ, Thụy Điển, Úc, United Arab Emirates, Ý, Đan Mạch
Velblastin	Ả Rập, Malaysia
Vinblasine	Luxembourg
Vinblastin	Ba Lan, Hungary
Vinblastina	Argentina, Chile, Colombia, Ecuador, Mexico, Peru, Romania, Tây Ban Nha
Vinblastine	Ả Rập Saudi, Anh, Bỉ, Canada, Hà Lan, Hoa Kỳ, Iran, Ireland, New zealand, Pháp, Tunisia, Úc
Vinblastinsulfat	Đức
Vinblatine	Malaysia
Vinko	Thổ Nhĩ Kỳ

Tài liệu tham khảo : Vinblastine sulfate

	Loại	Nguồn
3	Tạp chí	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81	Tạp chí	Trissel LA, Martinez JF. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 672-678.
84	Tạp chí	Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 495-499.
99	Tạp chí	Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
144	Tạp chí	Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML. Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags. Int J Pharm 1991 ; 77: 279-285.
167	Tạp chí	Francomb MM, Ford JL, Lee MG. Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters. Int J Pharm 1994 ; 103: 87-92.
169	Tạp chí	Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993 ; 50: 2359-2363.
182	Tạp chí	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
244	Tạp chí	Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913.
248	Tạp chí	Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993 ; 50: 300-304.
249	Tạp chí	Trissel LA, Martinez JF. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251	Tạp chí	Trissel LA, Gilbert DL, Martinez JF. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
307	Tạp chí	Trissel LA, Martinez JF. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1792-1799.
334	Tạp chí	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	Tạp chí	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
481	Tạp chí	Beijnen JH, Vendrig DEMM, Underberg WJM. Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids. J Parenter Sci Technol 1989 ; 43: 84-87.
492	Tạp chí	Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189.
763	Tạp chí	Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH. Drug precipitation within IV tubing : A potential hazard of chemotherapy administration. Cancer Treat Rep 1985 ; 69: 1325-1326.
827	Tạp chí	Black J, Buechter DD, Thurston DE. Stability of vinblastine sulfate when exposed to light. Drug Intell Clin Pharm 1988 ; 22: 634-636.
905	Tạp chí	Trissel LA, Martinez JF. Screening teniposide for Y-site physical incompatibilities. Hosp Pharm 1994 ; 29: 1010-1017.
921	Tạp chí	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1009	Tạp chí	Black J, Buechter DD, Chinn JW, Gard J, Thurston DE. Studies on the stability of vinblastine sulfate in aqueous solution. J Pharm Sci 1988 ; 77: 630-634.
1157	Tạp chí	Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM. Degradation kinetics of vinblastine sulphate in aqueous solutions. Int J Pharm 1988 ; 43: 131-138.
1229	Tạp chí	Weir PJ, Ireland DS. Chemical stability of cytarabine and vinblastine injections. Br J Pharm Pract 1990 ; 12: 53-54, 60.
1410	Tạp chí	Trissel LA, Martinez JF, Simmons M. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 141-145.
1423	Tạp chí	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1625	Tạp chí	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1727	Tạp chí	Mittner A, Vincze Z, Jemnitz K. Stability of vinblastine sulphate containing infusions. Pharmazie 1999 ; 54: 625-626.
1953	Tạp chí	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
3540	Thông tin của nhà sản xuất	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010
3578	Thông tin của nhà sản xuất	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3644	Thông tin của nhà sản xuất	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales